Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study-Reference-Cited by-同舟云学术

Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study

Published:1993-06 Issue:6 Volume:4 Page:475-479
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Buser K.S.,Joss R.A.,Piquet D.,Aapro M.S.,Cavalli F.,Haefliger J.M.,Jungi W.F.,Bauer J.,Obrist R.,Brunner K.W.,Weber T.,Verity L.,Butcher M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/4/6/475/430737/4-6-475.pdf

Reference13 articles.

1. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimens;Schmoll;Eur J Cancer Clin Oncol,1989

2. Ondansetron in the prophylaxis of actue cisplatin induced nausea and vomiting;Marty;Eur J Cancer Clin Oncol,1989

3. Ondansetron;Milne;The therapeutic use as an antiemetic. Drugs,1991

4. Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients;Pannuti;Eur J Cancer Clin Oncol,1988

5. Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma;Wilcox;Cancer Treat Rep,1982

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: a systematic review and meta-analysis;Supportive Care in Cancer;2022-08-12

2. Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice;Geburtshilfe und Frauenheilkunde;2019-03

3. Prevention of Nausea and Vomiting in Patients Undergoing Oral Anticancer Therapies for Solid Tumors;BioMed Research International;2015

4. Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study;Supportive Care in Cancer;2010-05-14

5. Antiemetic placebo: Reduce adverse drug interactions between chemotherapeutic agents and antiemetic drugs in cancer patients;Medical Hypotheses;2008-01